Long Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Long Chen has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Hua Zhu
Guangxi Key Laboratory of Zhuang and Yao Ethnic Medicine, Guangxi University of Chinese Medicine, Nanning, China
2 shared publications - Chennuo Zeng
Guangxi Key Laboratory of Zhuang and Yao Ethnic Medicine, Guangxi University of Chinese Medicine, Nanning 530200, China
1 shared publication - Chenyang Wang
School of Basic Medicine, GuangXi University of Chinese Medicine, Nanning 530200, China
1 shared publication - Dudong Wei
Guangxi Key Laboratory of Zhuang and Yao Ethnic Medicine, Guangxi University of Chinese Medicine, Nanning 530200, China
1 shared publication - Fengfeng Xie
Guangxi Key Laboratory of Zhuang and Yao Ethnic Medicine, Guangxi University of Chinese Medicine, Nanning 530200, China
1 shared publication - Jiahao Lu
Guangxi Key Laboratory of Zhuang and Yao Ethnic Medicine, Guangxi University of Chinese Medicine, Nanning 530200, China
1 shared publication
Latest Publications
- Open Access
- 2 November 2026
- Published by MDPI AG in Microorganisms
- Vol. 14 (11) , 2495
Plant Endophytic Microorganisms and Anticancer Natural Products: A Critical Reappraisal of Biosynthetic Evidence and Mechanistic Claims
Endophytic microorganisms have attracted considerable attention as a potential resource for the discovery and sustainable production of anticancer natural products. However, studies reporting the detection of target compounds from bacterial/fungal strains or elevated levels of these compounds in host plants do not constitute conclusive evidence that the microorganisms possess the capacity for independent de novo biosynthesis or are directly involved in their biosynthetic pathways. Therefore, there is a pressing need to establish an evaluation framework capable of distinguishing the genuine contribution of endophytes from false-positive signals. In this review, we systematically summarize research progress on endophytic microorganisms associated with paclitaxel, camptothecin, Catharanthus alkaloids, and podophyllotoxin as representative cases. We propose a central hypothesis that endophytes are dynamic participants in plant–microbe metabolic networks and can cooperate with their hosts to synthesize anticancer natural products through multiple mechanisms. A dual-standard evaluation system—comprising three levels of evidence and four categories of limitations—is employed to assess the quality of existing studies on microbial synthesis of plant-derived antitumor metabolites. Currently, a large number of reports remain at the level of mere in vitro culture and detection, lacking mechanistic evidence from genetic or isotopic tracing studies, which results in blurred boundaries between host residue and genuine microbial synthesis. We structurally classify endophytic contribution mechanisms into distinct types, including autonomous synthesis, host-induced synthesis, and co-metabolic conversion, and grade the quality of existing studies according to evidence strength. This dual-standard framework provides an evaluative basis for delineating the boundaries among autonomous synthesis, host induction, co-metabolic conversion, and contamination misassignment, while offering an evidence-based standard to guide the screening of anticancer endophyte resources, optimization of experimental design, and decision-making regarding microbial alternative production.
- 2 November 2026
- Published by MDPI AG in Microorganisms
- Vol. 14 (11) , 2495
Open AccessPlant Endophytic Microorganisms and Anticancer Natural Products: A Critical Reappraisal of Biosynthetic Evidence and Mechanistic Claims
Endophytic microorganisms have attracted considerable attention as a potential resource for the discovery and sustainable production of anticancer natural products. However, studies reporting the detection of target compounds from bacterial/fungal strains or elevated levels of these compounds in host plants do not constitute conclusive evidence that the microorganisms possess the capacity for independent de novo biosynthesis or are directly involved in their biosynthetic pathways. Therefore, there is a pressing need to establish an evaluation framework capable of distinguishing the genuine contribution of endophytes from false-positive signals. In this review, we systematically summarize research progress on endophytic microorganisms associated with paclitaxel, camptothecin, Catharanthus alkaloids, and podophyllotoxin as representative cases. We propose a central hypothesis that endophytes are dynamic participants in plant–microbe metabolic networks and can cooperate with their hosts to synthesize anticancer natural products through multiple mechanisms. A dual-standard evaluation system—comprising three levels of evidence and four categories of limitations—is employed to assess the quality of existing studies on microbial synthesis of plant-derived antitumor metabolites. Currently, a large number of reports remain at the level of mere in vitro culture and detection, lacking mechanistic evidence from genetic or isotopic tracing studies, which results in blurred boundaries between host residue and genuine microbial synthesis. We structurally classify endophytic contribution mechanisms into distinct types, including autonomous synthesis, host-induced synthesis, and co-metabolic conversion, and grade the quality of existing studies according to evidence strength. This dual-standard framework provides an evaluative basis for delineating the boundaries among autonomous synthesis, host induction, co-metabolic conversion, and contamination misassignment, while offering an evidence-based standard to guide the screening of anticancer endophyte resources, optimization of experimental design, and decision-making regarding microbial alternative production.
- Open Access
Gynura divaricata in the Modulation of Glucose and Lipid Metabolic Disorders: Research Advances and Translational Challenges
Glucose and lipid metabolism disorders are closely associated with type 2 diabetes mellitus (T2DM), obesity, hyperlipidemia, and metabolic dysfunction-associated steatotic liver disease (MASLD). Gynura divaricata (L.) DC., traditionally consumed as both a food and folk medicine, has attracted increasing attention for its potential regulatory effects on glucose and lipid metabolism. Existing in vitro and in vivo studies suggest that G. divaricata extracts and candidate bioactive constituents, including flavonoids, polysaccharides, phenolic acids, and peptides, may improve metabolic phenotypes such as hyperglycemia, dyslipidemia, and insulin resistance. These effects may involve the regulation of intestinal carbohydrate hydrolysis, insulin signaling, gut microbial homeostasis, pancreatic β-cell function, lipid metabolism, oxidative stress, and chronic inflammation. However, human evidence remains limited, and most studies have investigated compound formulations or combined interventions, which are insufficient to establish the clinical efficacy of G. divaricata as a standalone preparation. This review summarizes the major bioactive constituents of G. divaricata, reviews the current evidence for its glucose-lowering and lipid-regulating effects and related antioxidant and anti-inflammatory mechanisms, and discusses the limitations of existing research. This study aimed to provide a reference for elucidating the mechanisms by which G. divaricata regulates glucose and lipid metabolism and for its future clinical translation.
Open AccessGynura divaricata in the Modulation of Glucose and Lipid Metabolic Disorders: Research Advances and Translational Challenges
Glucose and lipid metabolism disorders are closely associated with type 2 diabetes mellitus (T2DM), obesity, hyperlipidemia, and metabolic dysfunction-associated steatotic liver disease (MASLD). Gynura divaricata (L.) DC., traditionally consumed as both a food and folk medicine, has attracted increasing attention for its potential regulatory effects on glucose and lipid metabolism. Existing in vitro and in vivo studies suggest that G. divaricata extracts and candidate bioactive constituents, including flavonoids, polysaccharides, phenolic acids, and peptides, may improve metabolic phenotypes such as hyperglycemia, dyslipidemia, and insulin resistance. These effects may involve the regulation of intestinal carbohydrate hydrolysis, insulin signaling, gut microbial homeostasis, pancreatic β-cell function, lipid metabolism, oxidative stress, and chronic inflammation. However, human evidence remains limited, and most studies have investigated compound formulations or combined interventions, which are insufficient to establish the clinical efficacy of G. divaricata as a standalone preparation. This review summarizes the major bioactive constituents of G. divaricata, reviews the current evidence for its glucose-lowering and lipid-regulating effects and related antioxidant and anti-inflammatory mechanisms, and discusses the limitations of existing research. This study aimed to provide a reference for elucidating the mechanisms by which G. divaricata regulates glucose and lipid metabolism and for its future clinical translation.
- Open Access
Curcumin Protects Mouse Spermatogonia from Triptolide-Induced Injury Through Modulation of Ferroptosis-Related Pathways
Triptolide (TP) is an effective anti-inflammatory and immunosuppressive agent, yet its clinical application is constrained by significant male reproductive toxicity. Curcumin, a natural antioxidant, exhibits protective effects; however, whether it protects against TP-induced damage during mouse spermatogenesis and the underlying mechanisms remain incompletely understood. Methods: Proteomic analysis was performed to investigate the protective mechanism of curcumin in mouse GC-1 cells, followed by multiple validation assays including CCK-8 assay, apoptosis detection, measurement of reactive oxygen species (ROS), glutathione (GSH), malondialdehyde (MDA), and Fe2+ levels, quantitative polymerase chain reaction (qPCR), Western blotting (WB), hematoxylin-eosin (HE) staining, and immunofluorescence. Results: Proteomic analysis revealed that curcumin primarily ameliorated TP-induced damage in mouse spermatogonia by modulating ferroptosis-related pathways. Curcumin elevated GSH levels; reduced MDA, ROS, and Fe2+ levels; alleviated lipid peroxidation; and regulated ferroptosis-related pathways in both TP-induced GC-1 cells and testicular tissue. These effects were associated with upregulation of the mRNA and protein expression of Nrf2, Gclc, and Map1lc3a and downregulation of Tfrc and Dmt1. Collectively, these findings demonstrate the protective effect of curcumin against TP-induced spermatogonial damage. Conclusions: Curcumin regulated ferroptosis-related pathways by modulating the expression of Nrf2, Gclc, Map1lc3a, Tfrc, and Dmt1, thereby significantly ameliorating TP-induced damage in mouse spermatogonia.
Open AccessCurcumin Protects Mouse Spermatogonia from Triptolide-Induced Injury Through Modulation of Ferroptosis-Related Pathways
Triptolide (TP) is an effective anti-inflammatory and immunosuppressive agent, yet its clinical application is constrained by significant male reproductive toxicity. Curcumin, a natural antioxidant, exhibits protective effects; however, whether it protects against TP-induced damage during mouse spermatogenesis and the underlying mechanisms remain incompletely understood. Methods: Proteomic analysis was performed to investigate the protective mechanism of curcumin in mouse GC-1 cells, followed by multiple validation assays including CCK-8 assay, apoptosis detection, measurement of reactive oxygen species (ROS), glutathione (GSH), malondialdehyde (MDA), and Fe2+ levels, quantitative polymerase chain reaction (qPCR), Western blotting (WB), hematoxylin-eosin (HE) staining, and immunofluorescence. Results: Proteomic analysis revealed that curcumin primarily ameliorated TP-induced damage in mouse spermatogonia by modulating ferroptosis-related pathways. Curcumin elevated GSH levels; reduced MDA, ROS, and Fe2+ levels; alleviated lipid peroxidation; and regulated ferroptosis-related pathways in both TP-induced GC-1 cells and testicular tissue. These effects were associated with upregulation of the mRNA and protein expression of Nrf2, Gclc, and Map1lc3a and downregulation of Tfrc and Dmt1. Collectively, these findings demonstrate the protective effect of curcumin against TP-induced spermatogonial damage. Conclusions: Curcumin regulated ferroptosis-related pathways by modulating the expression of Nrf2, Gclc, Map1lc3a, Tfrc, and Dmt1, thereby significantly ameliorating TP-induced damage in mouse spermatogonia.